Doctor profile · Federal record
Dr. Alan Epstein, M.D.
Rheumatology Physician (CMS: Rheumatology) · Philadelphia, PA
- NPI 1346211844
- Accepts Medicare
- MIPS 98.7 / 100 · 2023
- 47 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
822 Pine St, Ste 3A
Philadelphia, PA 191076187
(215) 829-5358
fax (215) 923-6442
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- June 17, 2022
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Pennsylvania #MD033529E
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346211844. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
46,217
Distinct HCPCS
10
Medicare allowed
$841,302
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 19,126 | 23 | $13 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 14,700 | 14 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 9,780 | 95 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,118 | 437 | $134 | |
36415 |
Insertion of needle into vein for collection of blood sample | 449 | 239 | $8 | |
96372 |
Injection of drug or substance under skin or into muscle | 315 | 104 | $15 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 195 | 35 | $141 | |
J3489 |
Injection, zoledronic acid, 1 mg | 110 | 22 | $9 | |
J1030 |
Injection, methylprednisolone acetate, 40 mg | 104 | 67 | $8 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 79 | 28 | $69 |
In context: peer comparison
Among 31 peers in Philadelphia Rheumatology Physician, average services per provider: 860. This provider delivers 54× the peer median.Open Payments
Industry payments received
All-time total
$150,799
Transactions
175
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 32 | $67,305.75 | |
| Janssen Biotech, INC. | 24 | $24,447.26 | |
| Amgen INC. | 41 | $17,206.26 | |
| GlaxoSmithKline, LLC. | 10 | $11,858.90 | |
| Abbvie INC. | 46 | $11,154.59 | |
| AstraZeneca Pharmaceuticals Lp | 10 | $8,905.75 | |
| Fresenius Kabi USA, LLC | 1 | $5,500.00 | |
| Janssen Scientific Affairs, LLC | 1 | $2,565.00 | |
| Lilly USA, LLC | 2 | $1,575.00 | |
| Ucb, INC. | 6 | $247.86 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $16.79 | |
| Pfizer INC. | 1 | $16.10 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,565
Patients
578
Total drug cost
$40,522
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 544 | 147 | $4,669 |
| Meloxicam | Generic | 394 | 97 | $1,683 |
| Tramadol Hcl | Generic | 293 | 56 | $2,400 |
| Methotrexate (Methotrexate Sodium) | Brand | 172 | 40 | $4,572 |
| Gabapentin | Generic | 168 | 38 | $2,596 |
| Pregabalin | Generic | 150 | 26 | $2,334 |
| Tramadol Hcl-Acetaminophen (Tramadol Hcl/Acetaminophen) | Brand | 128 | 16 | $2,263 |
| Zolpidem Tartrate | Generic | 108 | 16 | $694 |
| Allopurinol | Generic | 104 | 25 | $1,734 |
| Alendronate Sodium | Generic | 103 | 23 | $1,126 |
Hospital affiliations
Frequently asked questions
What is Dr. Alan Epstein's medical specialty?
Dr. Alan Epstein practices Rheumatology Physician in Philadelphia, PA.
Where does Dr. Alan Epstein practice?
Dr. Alan Epstein practices at 822 Pine St, Philadelphia, PA 191076187. Office phone: 2158295358.
What is Dr. Alan Epstein's NPI?
Dr. Alan Epstein's National Provider Identifier (NPI) is 1346211844, issued by NPPES.
Does Dr. Alan Epstein accept Medicare assignment?
Yes. Dr. Alan Epstein accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Alan Epstein commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.